US FDA seeks additional data from Pfizer's tafamidis meglumine NDA
02:35 EDT 21 Jun 2012 | PharmaBiz
Pfizer Inc. has received a Complete Response Letter from the US Food and Drug Administration (FDA) on its New Drug Application (NDA) for tafamidis meglumine.
Original Article: US FDA seeks additional data from Pfizer's tafamidis meglumine NDA
More From BioPortfolio on "US FDA seeks additional data from Pfizer's tafamidis meglumine NDA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
